WHO Reporting System for Lung Cytopathology
SECURE PAYMENT
SHIPMENT
FREE RETURN
Informations
WHO Reporting System for Lung Cytopathology is Volume 1 of this
new series of reporting systems for cytopathology, which is a joint
project of the International Academy of Cytology (IAC) and the
International Agency for Research on Cancer (IARC), a specialized agency
of the World Health Organization (WHO). The series includes a unique
synthesis of the published evidence and the practice of cytopathology,
and it is linked to the WHO Classification of Tumours series, now in its 5th edition.
Cytopathologists look at tumours slightly differently than other
specialists do, and there is a need for specialized reporting systems
based on the key diagnostic cytopathological features of tumours,
presented in standardized reports, within a hierarchical system of
diagnostic categories. These categories must also be linked to
diagnostic management recommendations to improve communication with
clinicians and support patient care. And it is essential that these
reporting systems be truly international, to serve the needs of patients
worldwide in many differently medically resourced settings.
These volumes are an essential tool for standardizing diagnostic
cytopathology practice worldwide and will serve as a vehicle for the
translation of cytopathology research into practice. The key diagnostic
cytopathological features are listed for each tumour type under a
defined set of diagnostic categories and described in precise, uniform
language. These
diagnostic criteria represent the first international consensus and are
underpinned by evidence that has been evaluated and debated by experts
in the field. Each lesion-specific section includes a dedicated
subsection discussing the differential diagnosis of the cytopathological
features that can be used throughout the world, including in
low-resource settings, followed by a subsection describing the current
best-practice application of ancillary testing (including
next-generation sequencing) on cytopathology material.
This volume:
- Prepared by about 60 authors and editors
- Contributors from around the world, reflecting an international expertise
- More than 300 high-quality images
- More than 1000 references
- Shipping Information
- Files
Description
WHO Reporting System for Lung Cytopathology is Volume 1 of this
new series of reporting systems for cytopathology, which is a joint
project of the International Academy of Cytology (IAC) and the
International Agency for Research on Cancer (IARC), a specialized agency
of the World Health Organization (WHO). The series includes a unique
synthesis of the published evidence and the practice of cytopathology,
and it is linked to the WHO Classification of Tumours series, now in its 5th edition.
Cytopathologists look at tumours slightly differently than other
specialists do, and there is a need for specialized reporting systems
based on the key diagnostic cytopathological features of tumours,
presented in standardized reports, within a hierarchical system of
diagnostic categories. These categories must also be linked to
diagnostic management recommendations to improve communication with
clinicians and support patient care. And it is essential that these
reporting systems be truly international, to serve the needs of patients
worldwide in many differently medically resourced settings.
These volumes are an essential tool for standardizing diagnostic
cytopathology practice worldwide and will serve as a vehicle for the
translation of cytopathology research into practice. The key diagnostic
cytopathological features are listed for each tumour type under a
defined set of diagnostic categories and described in precise, uniform
language. These
diagnostic criteria represent the first international consensus and are
underpinned by evidence that has been evaluated and debated by experts
in the field. Each lesion-specific section includes a dedicated
subsection discussing the differential diagnosis of the cytopathological
features that can be used throughout the world, including in
low-resource settings, followed by a subsection describing the current
best-practice application of ancillary testing (including
next-generation sequencing) on cytopathology material.
This volume:
- Prepared by about 60 authors and editors
- Contributors from around the world, reflecting an international expertise
- More than 300 high-quality images
- More than 1000 references
test
Shipping Information
Επιστροφές
ΠΟΛΙΤΙΚΗ ΕΠΙΣΤΡΟΦΩΝ
Στόχος μας είναι να εξασφαλίσουμε την απόλυτη ικανοποίησή σας. Αν για οποιονδήποτε λόγω, δεν μείνετε ευχαριστημένοι από την παραγγελία σας, μπορείτε να ασκήσετε το δικαίωμά σας να επιστρέψετε μέρος ή όλα τα προϊόντα που αγοράσατε εντός δεκατεσσάρων (14) ημερών από την ημερομηνία παραλαβής. Αν δεν υπάρχει διαθέσιμο
το ανάλογο προϊόν που επιθυμείτε, το ποσό διαφοράς που προκύπτει διατηρείται στον λογαριασμό σας για να το χρησιμοποιήσετε για μία άλλη αγορά. Θα γίνεται αποδεκτή μόνο η επιστροφή των προϊόντων που βρίσκονται σε άριστη κατάσταση. Παρακαλώ, σημειώστε ότι η αποστολή του μη επιθυμητού προϊόντος γίνεται με εταιρεία courier με χρέωση της εταιρίας μας. Η αποστολή του νέου προϊόντος γίνεται μέσω εταιρεία courier με χρέωση πελάτη.
ΕΛΛΑΤΩΜΑΤΙΚΟ ΠΡΟΙΟΝ
Στην περίπτωση που λάβετε ένα ελαττωματικό ή κατεστραμμένο προϊόν το βιβλιοπωλείο μας θα καταβάλλει κάθε προσπάθεια για να αντικατασταθεί με ένα ίδιο ή παρόμοιο προϊόν χωρίς κάποιο επιπλέον κόστος για σας.
Παρακαλούμε επικοινωνήστε μαζί μας με e-mail στο ipokratis@ipokratis.gr ή στο 2310212212 για περαιτέρω διευκρινήσεις.
